Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT06840288
- Status
- Recruiting
Conditions
- Thoracic Tumors
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors.
Key Dates
- Start date
- Feb 19, 2025
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2034
- Completion
- Dec 31, 2036
Study Design
- Enrollment
- 250 participants (estimated)
Arms
- Arm: Small Thoracic Tumors
Primary Outcome Measure
To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors. [ Time Frame: Through study completion, an average of 1 year. ]
Central Contacts
- Roberto F Casal, MD(713) 792-6238
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MD Anderson Cancer Center | Houston | Texas | 77030 |
Find similar trials in Houston, TX
By research site